Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Mechanical Thrombectomy in Anticoagulated Patients with Acute Ischemic Stroke, A Meta-Analysis
Neurologist 29:194-203, Zhang,H.L.,et al, 2024
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke
Neurol 103:e209862, Theodorou,A.,et al, 2024
Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024
Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants
JAMA Neurol 78:515-518, Seiffge, D.J.,et al, 2021
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018
Stroke
Lancet 389:641-654, Hankey, G.J., 2017
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003
Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003
How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000
New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000
Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
The Effect of Multiple Neuroimaging Studies on Classification, Treatment and Outcome of Acute Ischemic Stroke
Ann Int Med 124:21-26, Salerno,S.M.,et al, 1996
Evolving Stroke and the Ischemic Penumbra
Neurol 47:884-888, Fisher,M.&Garcia,J.H., 1996
Stroke and Transient Ischaemic Attacks
JNNP 57:534-543, Humphrey,P., 1994
Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993
Pathophysiology of Acute Ischaemic Stroke
Lancet 339:533-536, Pulsinelli,W., 1992
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Primary Intraventricular Hemorrhage:Clinical & Neuropsychological Fundings in a Prospective Stroke Series
Neurol 38:68-75, Darby,D.G.,et al, 1988
Cerebellar Stroke
Editorial, Lancet 1:1031-10321988., , 1988
Controversies in the Management of Cerebral Vascular Disease
Neurol 38:1609-1616, Scheinberg,P., 1988
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
Cerebral Venous Thrombosis-A Review of 38 Cases
Stroke 16:199-213, Bousser,M.,et al, 1985
Lesions in Cerebrovascular Disease & their Clinical Implications
BMJ 89, Hutchinson,E.C., 1972